Plasma acylcarnitines could predict prognosis and evaluate treatment of IgA nephropathy

BACKGROUND: Effective evaluation or prediction of therapy response could be helpful for treatment of chronic kidney disease (CKD), which may rely on accurate biomarkers. Acylcarnitines are involved with lipid metabolism and mitochondrial function. The relation of acylcarnitines with treatment respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Fang-Ying, Zhu, Li, Xu, Chao, Wu, Qing-Qing, Chen, Wan-Jia, Zeng, Rong, Deng, Yue-Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323753/
https://www.ncbi.nlm.nih.gov/pubmed/30631376
http://dx.doi.org/10.1186/s12986-018-0328-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323753/
https://www.ncbi.nlm.nih.gov/pubmed/30631376
http://dx.doi.org/10.1186/s12986-018-0328-1

Ejemplares similares